INNOSPEC INC

For the period ended Jun 30, 2024. Filed Aug 7, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 7, 2024

IOSP$77.72-3.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheets

(in millions, except share and per share data)	June 30,2024	December 31,2023
Assets
Current assets:
Cash and cash equivalents	$240.2	$203.7
Trade and other accounts receivable (less allowances of $9.4 million and $10.3 million respectively)	300.3	359.8
Inventories (less allowances of $38.0 million and $28.1 million respectively):
Finished goods	210.9	215.7
Raw materials	102.6	84.4
Total inventories	313.5	300.1
Prepaid expenses	9.7	18.7
Prepaid income taxes	12.1	2.8
Other current assets	1.0	0.6
Total current assets	876.8	885.7
Net property, plant and equipment	271.9	268.3
Operating lease right-of-use assets	47.9	45.1
Goodwill	388.2	399.3
Other intangible assets	61.4	57.3
Deferred tax assets	10.4	10.4
Pension asset	37.0	35.1
Other non-current assets	6.7	6.2
Total assets	$1,700.3	$1,707.4

Liabilities and Equity
Current liabilities:
Accounts payable	$147.7	$163.6
Accrued liabilities	143.1	185.9
Current portion of operating lease liabilities	14.9	13.6
Current portion of plant closure provisions	4.6	4.6
Current portion of accrued income taxes	21.3	2.6
Current portion of unrecognized tax benefits	1.2	1.2
Total current liabilities	332.8	371.5
Operating lease liabilities, net of current portion	33.2	31.6
Plant closure provisions, net of current portion	56.5	57.0
Accrued income taxes, net of current portion	—	11.6
Unrecognized tax benefits	10.7	13.6
Deferred tax liabilities	35.4	33.5
Pension liabilities and post-employment benefits	12.7	13.3
Acquisition-related contingent consideration	20.2	23.4
Other non-current liabilities	2.9	2.3
Total liabilities	504.4	557.8
Equity:
Common stock, $0.01 par value, authorized 40,000,000 shares, issued 29,554,500 shares	0.3	0.3
Additional paid-in capital	364.5	361.0
Treasury stock (4,613,079 and 4,686,511 shares at cost, respectively)	(93.4)	(94.3)
Retained earnings	1,081.8	1,028.2
Accumulated other comprehensive loss	(160.6)	(148.1)
Total Innospec stockholders’ equity	1,192.6	1,147.1
Non-controlling interest	3.3	2.5
Total equity	1,195.9	1,149.6
Total liabilities and equity	$1,700.3	$1,707.4

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.